MAHWAH, N.J., March 3, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch 1 of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results